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Abstract Lipopolysaccharides (LPSs) are ubiquitous and vital
components of the cell surface of Gram-negative bacteria that
have been shown to play a relevant role in the induction of the
immune-system response. In animal and plant cells, innate
immune defenses toward microorganisms are triggered by the
perception of pathogen associated molecular patterns. These
are conserved and generally indispensable microbial structures
such as LPSs that are fundamental in the Gram-negative im-
munity recognition. This paper reports the development of an
integrated strategy based on lipopolysaccharide affinity meth-
odology that represents a new starting point to elucidate the
molecular mechanisms elicited by bacterial LPS and involved
in the different steps of innate immunity response. Biotin-
tagged LPS was immobilized on streptavidin column and used
as a bait in an affinity capture procedure to identify protein
partners from human serum specifically interacting with this
effector. The complex proteins/lipopolysaccharide was isolated
and the protein partners were fractionated by gel electrophore-
sis and identified by mass spectrometry. This procedure proved
to be very effective in specifically binding proteins functionally
correlated with the biological role of LPS. Proteins specifically
bound to LPS essentially gathered within two functional
groups, regulation of the complement system (factor H, C4b,
C4BP, and alpha 2 macroglobulin) and inhibition of LPS-
induced inflammation (HRG and Apolipoproteins). The
reported strategy might have important applications in the
elucidation of biological mechanisms involved in the LPSs-
mediated molecular recognition and anti-infection responses.
Keywords Innate immunity . Lipopolysaccharide .
Proteomics . Affinity
Introduction
In a biological context, the term immunity refers to the set of
events and biological cascades that protect organisms against
infectious diseases. This protection system is based on com-
plex interconnections between cells and molecules whose
synergic action determines immune response. The main phys-
iological function of the immune system is the protection
against infectious agents or simply against exogenous ele-
ments. The ability to distinguish “self” from “non-self” is
critical to prepare an effective immune response [1].
Immune system response can be classified into two cate-
gories: adaptive immunity and innate immunity. The adaptive
immune system is based on specialized processes whose
function is to eliminate external threats during the late phase
of infection with the generation of immunological memory.
Specificity is developed by clonal gene rearrangements from a
range of antigen-specific receptors on lymphocytes [2]. Only
vertebrates are provided with this type of immunity, allowing
the organism to recognize and remember the “non-self.” In-
nate immune system is necessary to activate adaptive immune
system. It acts in a non-specific manner and does not confer
any memory of the challenge. It is widespread among all
animals and even in plants, and its main function is to provide
immediate protection against pathogens. Innate immunity
relies on specific cells as primary mediators, namely phago-
cytic cells and antigen presenting cells, such as granulocytes,
macrophages, and dendritic cells [3]. Innate immunity mech-
anisms do not have specific pathogen targets, the principal
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targets are evolutionarily conserved molecular structures,
termed “pathogen associated molecular patterns” (PAMPs)
whose expression is common to different pathogens. These
structures are generally recognized by receptors on the mem-
brane of the host cells that are responsible for the immune
response. Such structures are called “pattern recognition
receptors” (PRR). PRRs are constitutively expressed in the
host on all cells of a given type [4]. Lipopolysaccharide (LPS)
is a glycolipid, generally referred to as endotoxin in Gram
negative bacteria, belonging to PAMP family. It is a potent
inducer of the innate immune system and the main cause of
septic shock [5].
The recognition of this endotoxin is achieved by the
interplay of a variety of proteins, either receptors or serum
secreted proteins. The cascades of events following LPS
infection has been investigated in numerous studies. How-
ever, most of them focused on the interaction of single
specific proteins with LPS, such as the LPS-binding protein
(LBP), whose mechanism of action was clarified in many
works [6, 7]. Further studies showed that other proteins
possess LPS-binding domains [8–10]. Intracellular path-
ways elicited by LPS infection was investigated by in vitro
and in vivo analyses on different cell types, ranging from
immune cells to epithelial cells [11, 12].
Toll-like receptor 4 (TLR-4) is the signal transducing
receptor of lipopolysaccharides; lipid A is the real effector
required to activate TLR4 signaling pathway in conjunction
with a soluble co-receptor protein myeloid differentiation
protein 2 (MD2), which directly and physically binds to
LPS [13, 14]. Entry of LPS or lipid A into the blood stream
is responsible for the onset of septic shock [15]. Aggregates
of LPS bind to certain plasma proteins, such as albumin,
LBP and soluble CD14 to facilitate the interaction with host
cells, via TLR4. The complex of protein bound to LPS,
TLR4, and MD2, activates two intracellular pathways [16]:
the MyD88-dependent pathway, responsible for early-phase
NF-κB andMAPK activation, which controls the induction of
proinflammatory cytokines TNF-a, IL-1, and IL-6 and the
MyD88-independent, TRIF-dependent pathway that activates
IRF3, which is necessary for the induction of IFN-β- and
IFN-inducible genes [17]. The activation of the TLR4-MD2
complex triggers the induction of inflammatory cytokines
acting as endogenous mediator of infection, as well as the
superoxide anion (O2
−), hydroxyl radicals (OH), nitric oxide,
and antimicrobial peptides [18].
The low and balanced concentrations of these mediators
as well as the presence of soluble immune response modu-
lators lead to a resulting inflammation, which is one of the
most important and ubiquitous aspect of the immune host
defense against invading microorganisms. Beside these pos-
itive effects, an uncontrolled and massive immune response,
due to the circulation of large amount of endotoxins, leads
to the symptoms of the sepsis and of the septic shock.
Therefore, identification of all the molecular actors involved
in the recognition cascade is of pivotal importance with par-
ticular emphasis on the differences in elicitation and reaction
by different LPSs.
Numerous studies have been performed following pro-
inflammatory expression patterns via microarray analyses
[19] and the phage display method was used to capture new
LPS-binding peptides [20].
Recently, proteomics approaches were addressed to the
study of innate immunity. Comparative analysis of the hu-
man plasma proteome prior and after LPS injection was
performed [21] and the human innate immunity interactome
was investigated using 58 genes involved in transcriptional
regulation of type I IFN tagged with the FLAG epitope
following cells stimulation with LPS [22].
The aim of this study was the setting up of a new
methodology for the development of lipopolysaccharides
analyses to be used to capture LPS-interacting proteins in
order to better elucidate the molecular mechanism of the
innate immunity. Here, a strategy based on chemical manip-
ulations, biochemical procedure and mass spectrometry
techniques integrated in a functional proteomic workflow
is proposed. The procedure was developed using an LPS
derived from Salmonella typhimurium, and the proteomic
study was carried out by using human serum from a healthy
donor as a model.
Materials and methods
LPS extraction
Dried cells of S. typhimurium were extracted by the phenol/
water method [23]. The extracted phases were dialyzed
three times against distilled water and subjected to enzymat-
ic digestions in order to remove nucleic acids and protein
contaminants. Both water and phenol fractions were ana-
lyzed through sodium dodecyl sulphate–polyacrylamide gel
electrophoresis (SDS-PAGE) 12.5 % and LPS bands were
evidently present in the water phase (data not shown). The
LPS was further purified and analyzed as described [24].
Briefly, extract was first both digested with DNase, RNase,
and Proteinase K, dialyzed, lyophilized, and further purified
by gel filtration chromatography on Sephacryl S-500 (yield,
4.3 % of the dry mass). The LPS was further analyzed for its
carbohydrate composition which resulted to be the one
expected in S. typhimurium LPS, with mannose galactose,
glucose, rhamnose, and abequose.
LPS biotinylation
LPS biotinylation was achieved by a transesterification
reaction with biotin-p-nitrophenylester (Sigma Aldrich).
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Three milligrams of lyophilized LPS were solubilized in
200 μL pyridine (Romil), to which a 9-mg of biotin-p-nitro-
phenylester was added. LPS/biotin-p-nitrophenylester ratio
was calculated as 1:3 (weight/weight). The reaction was
carried out in the dark for 2 h at 80 °C. The reaction mixture
was dried under nitrogen and then the sample was dissolved
in MilliQ water. The excess of reagents was removed by
molecular exclusion chromatography on PD-10 columns
(GE-Healthcare). This is a fast and high recovery desalting
procedure based on disposable columns. The sample was
applied to the top of the column and eluted in water by
gravity flow. LPS, being larger than the pores of the matrix
was eluted first, whereas salts and the excess of reagents,
penetrating the pores, were eluted after LPS, just before the
total volume of the column. LPS containing fractions were
pooled and lyophilized. Unlabeled and biotinylated LPS
were dissolved in Laemmli buffer, supplemented with
100 mM dithiothreitol (DTT) and separated by SDS-PAGE
in a 12.5 % polyacrylamide gel. LPS was detected by silver
nitrate staining for carbohydrates (Tsai Frash, 1982) or
electrotransferred onto a polyvinylidene fluoride mem-
brane (Millipore). The membrane was blocked with 3 %
non fat dry milk, 1 % bovine serum albumin (Sigma
Aldrich), in PBS containing 0.05 % Tween 20 (Sigma
Aldrich). Then it was incubated with 1:1,000 streptavi-
din/HRP conjugate (Sigma Aldrich). Biotinylated sample
was detected using SuperSignal West FemtoChemilumi-
nescent Kit from Pierce.
LPS immobilization onto avidin beads
Biotin-LPS immobilization was carried out using 3 mg
biotin-LPS/mL of settled avidin agarose resin (settled gel,
Pierce)
An aliquot of resin was extensively washed with binding
buffer (0.1 M Na3PO4; 0.3 M NaCl; pH 7.2) and incubated
with biotin-LPS at 4 °C overnight under shaking. Then the
resin was washed three times with binding buffer.
Biotin-LPS and human serum interaction
The affinity experiment was preceded by a “precleaning
step.” A protease inhibitors cocktail (Sigma Aldrich) was
added to 5 mg human serum (Servizio Analisi, Policlinico),
to a final concentration of 1 mM. This sample was diluted to
a final volume of 600 μL with binding buffer and incubated
with 150 μL of settled resin overnight at 4 °C. The unbound
fraction of precleaning step was therefore incubated with
150 μL of biotin-LPS immobilized resin overnight at 4 °C.
Later on, both aliquots of resin, that we term “control” and
“sample,” were subjected to repeated washes with binding
buffer. Elution was performed boiling the resin in Laemmli
buffer and DTT.
SDS-PAGE was performed, loading on a 1.5 mm, 12.5 %
gel all the samples deriving from the different steps of the
affinity experiment. The gel was run at constant 25 mA for
1 h. The gel was stained with colloidal Coomassie (Pierce).
In gel trypsin digestion
The analysis was performed on the Coomassie blue-stained
protein bands excised from the gels. Gel particles were
washed first with acetonitrile and then with 0.1 M ammoni-
um bicarbonate. Protein samples were reduced incubating
the bands with 10 mM DTT for 45 min at 56 C. Cysteines
were alkylated by incubation in 5 mM iodoacetamide for
15 min at room temperature in the dark. The bands were
then washed with ammonium bicarbonate and acetonitrile.
Enzymatic digestion was carried out with trypsin (12.5 ng/μL)
in 50 mM ammonium bicarbonate buffer, pH 8.5. Gel par-
ticles were incubated at 4 °C for 2 h, in order to allow the
enzyme to enter the gel. The buffer solution was then removed
and a new aliquot of buffer solution was added for 18 h at
37 C. A minimum reaction volume, enough for complete gel
rehydration was used. At the end of the incubation the pep-
tides were extracted by washing the gel particles 0.1 % formic
acid in 50 % acetonitrile at room temperature and then
lyophilised.
LC-MS/MS analyses
Peptides mixtures were analyzed by liquid chromatography-
tandem mass spectrometry (LC-MS/MS), using a HPLC-
Chip LC system (Agilent 1200) connected to a Q-TOF
6520 (Agilent Technologies). Samples were diluted in
10 μL of 0.1 % formic acid. After loading, the peptide
mixtures were concentrated and washed at 4 μL/min in
40 nL enrichment column with 0.2 % formic acid in 2 %
acetonitrile. Fractionation was carried out on a C-18 reverse
phase column (75 μm×43 mm) at a flow rate of 0.4 μL/min
with a linear gradient of eluent B (95 % acetonitrile and
0.2 % formic acid) in A (2 % acetonitrile and 0.1 % formic
acid) from 7 to 80 % in 51 min.
Mass spectrometry analyses were performed using data-
dependent acquisition MS scans (mass range, 300–2,400 m/z),
followed by MS/MS scans (mass range, 100–2,000 m/z) of the
most intense ions of a chromatographic peak.
Raw data from LC-MS/MS were converted to mzData.
The spectra were searched against the NCBI database
(2006.10.17 version) using the licensed version of Mascot
2.1 (Matrix Science). The MASCOT search parameters
were: taxonomy Homo sapiens; allowed number of missed
cleavages 2; enzyme trypsin; variable post-translational
modifications, methionine oxidation, and pyro-glu N-term
Q; peptide tolerance 10 ppm and MS/MS tolerance 0.6 Da;
and peptide charge from +2 to +3.
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Results
An overview of the procedure, displaying the scheme of
sample preparation till MS was provided in Fig. 1.
LPS were extracted by S. typhimurium cells as described
in “Materials and methods” and analyzed by SDS-PAGE.
The LPS fraction was found exclusively in the water phase
as suggested by the presence of the typical ladder pattern in
the gel analysis (data not shown).
LPS tagging
Immobilisation of the LPS represents the key step in the
entire strategy to generate a labeled bait that could be linked
to agarose beads. Biotinylation of LPS was chosen as the
best suited derivatization process both for the simple mod-
ification reaction and to take advantage of the strong and
specific interaction of biotin with avidin.
Biotinylated LPS was analyzed by SDS-PAGE following
both silver staining and immunodetection with streptavidin/
HRP conjugate. Figure 2 shows the corresponding gel.
Staining procedures displayed the occurrence of two
sample bands. The low molecular mass bands corre-
sponds to the lipid A core component of LPS (R-type
LPS) whereas the high molecular mass band represents
the whole LPS molecule comprising the O-chain moiety
(S-type LPS). Both components were responsive to
western blot analysis demonstrating that they had been
derivatized by biotin.
LPS immobilization
Biotin-LPS was conjugated to avidin agarose beads by
incubation in 0.1 M Na3PO4 overnight. Both unbound and
bound fractions were analyzed by SDS-PAGE followed by
blotting and incubation with streptavidin/HRP conjugate.
Figure 3 shows the results of the immobilization procedure;
two responsive bands corresponding to LPS and the lipid A
moiety were clearly detected in the bound fraction while no
responsive bands occurred in the unbound material.
Fig. 1 Overview of the
strategy. Lipopolysaccharide by
S. typhimurium was extracted
by phenol/water extraction and
derivatized with biotin-p-nitro-
phenyl ester. Human serum was
incubated with avidin agarose
beads in order to detect a spe-
cific interaction between the
resin and the beads (precleaning
step giving rise to “Control”).
Then, the unbound coming
from the precleaning was incu-
bated with avidin agarose beads
after their incubation with
biotin-LPS (“Sample”).
“Control” and “Sample” were
analyzed by SDS-PAGE, the
bands were in situ digested, and
proteins identified by
LC-MS/MS
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Identification of LPS-interacting proteins
The final step of the proposed strategy relies on the use of
the immobilized LPS as bait in a functional proteomic
experiment [25] aiming at capturing specific LPS interactors
to investigate innate immunity molecular mechanisms in
human serum. An aliquot of human serum proteins was
incubated with underivatized avidin agarose beads over-
night at 4 °C as a pre-cleaning step to remove all the proteins
that non-specifically interact with agarose or avidin. The
unbound fraction was then incubated with biotin-LPS avidin
agarose beads and after extensively washing in binding
buffer both bound fractions (control and sample) were indi-
vidually eluted in Laemmli buffer and fractionated by SDS-
PAGE gel. An aliquot of 15 μg of human serum was also
loaded onto the gel (Fig. 4). Due to the complexity of the gel
patterns and the low resolution of 1D electrophoresis, sev-
eral proteins can occur in the same gel band. Therefore,
protein bands specifically present in the sample lane and
absent in the control lane cannot be identified by simply
comparing the two gel profiles. Thus the entire sample lane
of the gel was cut in 25 slices. Each slice was destained and
in situ trypsin digested. To check for non specific proteins,
the same procedure was applied to the control lane. The
resulting peptide mixtures were extracted from the gel and
submitted to nano-LC-MS/MS analysis generating sequence
information on individual peptides.
This information, together with the peptide mass values,
was then used to search protein databases using an in house
version of the Mascot software, leading to the identification
of the protein components. The experiments were performed
in two biological replicates and each protein mixture was
run through LC-MS/MS three times. All proteins identified
in both the sample and control lanes were discarded, while
only those solely occurring in the sample lane and absent in
the control lane were selected as putative LPS interactions.
All the proteins identified in this study have a score greater
Fig. 2 SDS-PAGE of LPS after
biotin-p-nitrophenylesterderiva-
tition detected by silver staining
(on the left) and blotting with
streptavidin/HRP incubation
(on the right). The figures rep-
resent an entire lane of LPS.
Nevertheless, protein markers
have been added in the figure in
order to compare LPS elecro-
phoretic mobility with protein
markers. A biological replicate
is provided in (b)
Fig. 3 Immobilization procedure probed by blotting with streptavidin/
HRP incubation. Two bands corresponding to LPS and lipid A moiety
were clearly detected in the bound fraction while no bands occurred in
the unbound material. A biological replicate is provided in (b)
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than the significance threshold, whose value was set at 0.05.
This represents the probability that the match is a random
event and is correlated to the score by the rule S0−10*Log
P, where S is the Mascot score and P is the probability of the
random event, implying that if a protein fall in the region of
probability of ≤0.05, the hit could be a random match. All
the identified proteins had a score greater than the threshold
indicating identity or extensive homology. In addition to
this, BLAST search engine has been used to assess if a
peptide sequence is unique for one particular protein or for
one particular organism. The research has been run using
SwissProt as database. As further selection criteria, only
proteins found in both biological replicates and identified
with at least two significant peptides in MASCOT search
were considered, providing a full list of putative LPS inter-
actors. The results are summarized in Table 1, where even
the peptide sequences are also reported.
Discussion
Lipopolysaccharides are major constituents of the outer mem-
brane of Gram-negative bacteria and important molecules in
the induction of the immune system response. The innate
immune system constitutes the first line of defense against
microorganisms and plays a primordial role in the activation
and regulation of adaptive immunity. In humans, components
of the innate immune system include members of the comple-
ment cascade and soluble pattern recognitionmolecules which
act as functional ancestors of antibodies [26]. In particular, the
complement system plays a key role in the elimination of
micro-organisms after entrance in the human host.
The integrated strategy based on functional proteomic
approach described in this paper represents a new starting
point to elucidate the molecular mechanisms elicited by
bacterial LPS and involved in the different steps of innate
immunity response. Identification of the specific LPS-
binding proteins in human serum was rarely addressed since
most investigations focused on the LPS-mediated effects on
cellular pathways and transcriptional responses. Only re-
cently, a similar approach using covalently immobilized
LPS [27] or lipotechoic acid [28] to screen for serum bind-
ing proteins was reported. In this procedure, following cou-
pling to the bait, a further defunctionalization step was
needed to chemically block any residual reactive group.
Moreover, depletion of the most abundant serum proteins
might have also caused the removal of the putative LPS or
LTA-binding proteins. The article by Kim et al. describes a
very similar approach, based on LPS-immobilized solid
support to screen for LPS-binding proteins in human se-
rum. Yet, the use of a depletion kit, allowing the removal
of the most abundant proteins, could lead to the elimina-
tion of potential LPS-binding proteins from the system. In
addition to this, most of the proteins, though already
reported as innate immunity elicitors, are identified with
only one peptide.
The strategy based on affinity capture procedure using
biotin LPS as a bait was optimized and non-depleted human
serum from a healthy donor was used as model. A number
of proteins were specifically retained by the LPS bait and
subsequently identified by mass spectrometric methodolo-
gies. The identity of these proteins represented per se a
validation of the developed affinity-capture procedure.
These proteins, in fact, essentially gathered within two func-
tional groups, regulation of the complement system (factor
H, C4b, C4BP, and alpha 2 macroglobulin) and inhibition of
LPS induced inflammation (HRG and Apolipoproteins).
Both groups are functionally correlated with the biological
Fig. 4 12.5 % SDS-PAGE gel containing 15 μg of human serum
together with control and sample bound fractions after elution in
Laemmli buffer. The term “Control” refers to the proteins bound to
the avidin agarose system during the precleaning step. The term “Sam-
ple” refers to the proteins specifically binding to the biotin-LPS
adsorbed to the avidin agarose. The entire control and sample lanes
of the gel were cut in 25 slices, as reported in the figure. Each slice was
destained and trypsin digested, in situ. A biological replicate is pro-
vided in (b)
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Table 1 List of putative LPS-interacting proteins after in situ digestion of the bands from control and sample bound fractions
Sample Protein ID Score Peptides
3 Alpha-2-macroglobulin P01023 170 QTVSWAVTPK
QGIPFFGQVR
AIGYLNTGYQR
VTAAPQSVCALR
MVSGFIPLKPTVK
ALLAYAFALAGNQDK
VDLSFSPSQSLPASHAHLR
QQNAQGGFSSTQDTVVALHALSK
Factor H P08603 44 RPYFPVAVGK
SSNLIILEEHLK
4 Ceruloplasmin P00450 136 GAYPLSIEPIGVR
QSEDSTFYLGER
RQSEDSTFYLGER
LISVDTEHSNIYLQNGPDR
KLISVDTEHSNIYLQNGPDR
KAEEEHLGILGPQLHADVGDKVK
Phospholipase D P80108 114 FGSSLITVR
ILEGFQPSGR
LSGALHVYSLGSD
AQYVLISPEASSR
6 Coagulation factor II (Thrombin) P00734 56 ETAASLLQAGYK
VTGWGNLKETWTANVGK
GQPSVLQVVNLPIVERPVCK
KPVAFSDYIHPVCLPDRETAASLLQAGYK
S plasma protein P07225 140 YLVCLR
VYFAGFPR
QLAVLDKAMK
QSTNAYPDLR
SFQTGLFTAAR
QGASGIKEIIQEK
KVESELIKPINPR
7 Histidine rich glycoprotein precursor P04196 54 QIGSVYR
RPSEIVIGQCK
C4 binding protein C4bp P04003 266 QSTLDKEL
YTCLPGYVR
EDVYVVGTVLR
LMQCLPNPEDVK
LSLEIEQLELQR
FSAICQGDGTWSPR
GVGWSHPLPQCEIVK
TGTTLKYTCLPGYVR
KPDVSHGEMVSGFGPIYNYK
KPDVSHGEMVSGFGPIYNYKDTIVFK
KSRPANHCVYFYGDEISFSCHETSR
10 Beta 2-glycoprotein I P02749 91 VSFFCK
VCPFAGILENGAVR
TCPKPDDLPFSTVVPLK
GRTCPKPDDLPFSTVVPLK
TFYEPGEEITYSCKPGYVSR
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role of LPS. Interestingly, some of the LPS interactors
identified in this study were coincident with those reported
in other systems [28].
The complement system is an essential component of the
innate immune system that participates in elimination of
pathogens. Three different pathways synergistically contrib-
ute to the protection mechanism elicited by the complement
proteins, the classical pathway, the alternative pathway and
the lectin pathway. Despite the specific pathway they belong
to, complement proteins provide host defense towards bac-
terial infections by binding to cell surface components of
exogenous microorganisms. In contrast, pathogenic micro-
organisms have evolved several strategies to escape these
defence mechanisms. The most common procedure consists
in the recruitment of complement inhibitory proteins to the
bacterial surface thus impairing the immune system.
In this respect, the identification of well characterized
protein inhibitors of the complement system among the
LPS interactors has a clear biological significance. C4BP,
factor H, and alpha-2-macroglobulin are all complement
inhibitors able to downregulate activation of the classical,
alternative, and lectin pathways, respectively. Streptococcus
pyrogenes, the ethiologic agent of important human infec-
tions, was shown to bind factor H, C4BP, and other com-
plement proteins as a crucial step in the pathogenesis of
these infections [29]. Bordetella pertussis was able to escape
the classical pathway of complement by binding the classi-
cal pathway inhibitor C4BP. In addition, very recently, it
was shown that this pathogen can also evade the alternative
complement pathway by recruitment of factor H on the cell
surface [30].
On the other hand, alpha-2-macroglobulin exerts a specific
inhibitory activity towards the lectin pathway by binding the
mannose-binding lectin (MBL) and the MBL-associated ser-
ine proteases MASP-1 and MASP-2 [31]. Adding of alpha-2-
macroglobulin to human serum totally reversed killing of
Neisseria gonorrhoeae, preventing MBL-mediated activation
of the complement system [32].
However, the most effective complement inhibitor is
factor H, a soluble protein regulator controlling the alterna-
tive immune pathway [33]. Recognition and the binding to
factor H constitute the infection mechanism adopted by
several pathogens as a common immune evasion strategy.
In addition several recent reports pointed out that besides its
role as an alternative pathway downregulator, factor H has
an additional complement regulatory role in inhibiting acti-
vation of the classical pathway [34, 35].
A totally different biological role can be ascribed to the
second group of proteins identified by the LPS affinity
capture strategy. HRG and Apolipoproteins, in fact, are
known to exert protective effects against LPS induced sys-
temic inflammation preventing inhibition of the complement
immune system. HRG binds strongly to several complement
protein inhibitors including factor H and C4BP thus assist-
ing in maintenance of normal immune function and enhanc-
ing complement activation [36]. S. pyrogenes was shown to
Table 1 (continued)
Sample Protein ID Score Peptides
Proapolipoprotein A1 P02647 145 ATEHLSTLSEK
VQPYLDDFQKK
LLDNWDSVTSTFSK
QKVEPLRAELQEGAR
DSGRDYVSQFEGSALGK
13 Complement C4B P0C0L5 92 QGSFQGGFR
GSSTWLTAFVLK
VLSLAQEQVGGSPEK
18 Apolipoprotein D P05090 56 QAFHLGK
VLNQELR
19 Apolipoprotein A-IV precursor P06727 74 LLPHANEVSQK
ISASAEELRQR
IDQNVEELKGR
TQVNTQAEQLRR
24 Prolactin-inducible precursor P12273 64 NFDIPK
FYTIEILKVE
As selection criteria only proteins solely present in the sample lane and completely absent in the control lane were considered putative interactors.
Analyses were carried out in replicates and only proteins proteins present in both replicates and identified with at least two peptides in MASCOT
search were considered. The term “Sample” refers to the number of the gel slice where the protein was identified. In some slices, more than one
protein were identified. Peptides sequences were included in the table
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grow more efficiently in HRG-deficient plasma while the
presence of overexpressed HRG greatly increased clots for-
mation, bacterial entrapment and killing [37].
Apolipoproteins AI, A-IV, and D are all components of
the high-density lipoproteins that have long been reported to
bind bacterial LPS neutralizing its toxicity and preventing
initiation of innate immunity. More recently, evidences for
an Apo AI-LPS specific interaction have been obtained [38].
Moreover, the adenovirus mediated overexpression of this
protein led to protection of mice against LPS-mediated
systemic inflammation [39].
Conclusions
In conclusion, the novel LPS-mediated affinity capture strat-
egy developed in this paper proved to be very effective in
specifically binding proteins involved either in inhibiting the
activation of the complement system or in preventing bacterial
infection by sequestering the LPS moiety. Both processes are
of relevant biological significance and the results obtained
make sense with the bait used. Moreover, although a proper
sensitivity test was not performed, the LPS affinity procedure
led to the identification of low abundant serum proteins even
without any depletion step, like phospholipase D, whose
concentration in serum is considerably low. The sensitivity
of the LC-MS/MS analyses allowed us to identify specific
proteins even when the protein band showed only a very faint
staining. A further advantage of this procedure concerns the
possibility of determining both the proteins directly bound to
LPS bait and other components involved in the functional
complex but not linking the LPS moiety. It will now be
possible to foresee applications of this strategy to investigate
biological mechanisms exerted by pathogenic bacteria at the
molecular level and to possibly define new mechanisms of
infection.
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